Published in Immunity on May 01, 2007
Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature (2010) 3.68
Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev (2008) 2.40
Natural killer cell education and tolerance. Cell (2010) 2.02
The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat Rev Immunol (2011) 1.82
Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med (2010) 1.70
Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells. Am J Respir Crit Care Med (2013) 1.50
Adaptive immune responses mediated by natural killer cells. Immunol Rev (2010) 1.48
Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc Natl Acad Sci U S A (2008) 1.43
Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest (2008) 1.34
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med (2012) 1.32
The role of natural killer cells in curbing neuroinflammation. J Neuroimmunol (2007) 1.29
Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc Natl Acad Sci U S A (2011) 1.26
Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation (2010) 1.25
HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. J Clin Invest (2010) 1.18
PD-1+ memory phenotype CD4+ T cells expressing C/EBPalpha underlie T cell immunodepression in senescence and leukemia. Proc Natl Acad Sci U S A (2009) 1.14
What causes alopecia areata? Exp Dermatol (2013) 1.14
Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2. Proc Natl Acad Sci U S A (2010) 1.09
Regulatory NK-cell functions in inflammation and autoimmunity. Mol Med (2009) 1.09
Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A. PLoS One (2012) 1.09
Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells. Semin Immunol (2011) 1.05
Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells. J Clin Invest (2013) 1.03
The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection. J Immunol (2012) 1.03
Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition. J Immunol (2008) 0.98
Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses. Biol Blood Marrow Transplant (2009) 0.94
Natural killer cells: from basic research to treatments. Front Immunol (2011) 0.93
Regulation of NK cell repertoire and function in the liver. Crit Rev Immunol (2011) 0.93
Genetic disruption of CD8+ Treg activity enhances the immune response to viral infection. Proc Natl Acad Sci U S A (2013) 0.90
Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1. PLoS One (2012) 0.88
Regulation of the adaptive immune system by innate lymphoid cells. Curr Opin Immunol (2014) 0.88
Tregs and infections: on the potential value of modifying their function. J Leukoc Biol (2011) 0.88
Ligand dimensions are important in controlling NK-cell responses. Eur J Immunol (2010) 0.87
Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells. J Neuroimmunol (2008) 0.87
Natural killer cells and their receptors in multiple sclerosis. Brain (2012) 0.87
NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses. Front Immunol (2013) 0.86
Innate immune natural killer cells and their role in HIV and SIV infection. HIV Ther (2010) 0.85
Tissue-protective effects of NKG2A in immune-mediated clearance of virus infection. PLoS One (2014) 0.85
Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE. J Autoimmun (2011) 0.83
Maintenance of Immune Homeostasis through ILC/T Cell Interactions. Front Immunol (2015) 0.83
NKp46 regulates allergic responses. Eur J Immunol (2013) 0.82
Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation. J Allergy Clin Immunol (2013) 0.82
Boosting vaccine efficacy the natural (killer) way. Trends Immunol (2015) 0.82
A LysM and SH3-domain containing region of the Listeria monocytogenes p60 protein stimulates accessory cells to promote activation of host NK cells. PLoS Pathog (2011) 0.82
NK cells are required for costimulatory blockade induced tolerance to vascularized allografts. Transplantation (2012) 0.81
Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med (2017) 0.81
Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization independently and before signs of neuronal death. ASN Neuro (2013) 0.81
Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis. Int Immunol (2011) 0.81
NK cell education via nonclassical MHC and non-MHC ligands. Cell Mol Immunol (2016) 0.81
Mechanisms of self-nonself discrimination and possible clinical relevance. Immunotherapy (2009) 0.80
NK cells inhibit T-bet-deficient, autoreactive Th17 cells. Scand J Immunol (2012) 0.80
NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun (2016) 0.80
NK cells and their ability to modulate T cells during virus infections. Crit Rev Immunol (2014) 0.80
Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts. Immunology (2014) 0.80
Evolving immune circuits are generated by flexible, motile, and sequential immunological synapses. Immunol Rev (2013) 0.79
Regulatory T cells in B cell follicles. Immune Netw (2014) 0.79
TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells. J Immunol (2011) 0.78
Properties and applications of single-chain major histocompatibility complex class I molecules. Antioxid Redox Signal (2011) 0.77
Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirus. Proc Natl Acad Sci U S A (2010) 0.77
Depletion of B220(+)NK1.1(+) cells enhances the rejection of established melanoma by tumor-specific CD4(+) T cells. Oncoimmunology (2015) 0.77
Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy. Clin Exp Immunol (2015) 0.76
NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection. J Immunol (2016) 0.76
Activated mouse CD4(+)Foxp3(-) T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity. Cell Res (2012) 0.76
The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8(+) T Cells in Response to a Lethal Poxvirus Infection. Immunity (2015) 0.76
Unexpected role of clathrin adaptor AP-1 in MHC-dependent positive selection of T cells. Proc Natl Acad Sci U S A (2010) 0.76
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis. Front Immunol (2016) 0.75
"Natural Regulators": NK Cells as Modulators of T Cell Immunity. Front Immunol (2016) 0.75
Interleukin-16-producing NK cells and T-cells in the blood of tobacco smokers with and without COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Recognition and Regulation of T Cells by NK Cells. Front Immunol (2016) 0.75
Trypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B Cells. PLoS Pathog (2016) 0.75
Experimental arthritis: Mobilizing killer cells to combat CIA. Nat Rev Rheumatol (2011) 0.75
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med (2006) 15.04
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature (2005) 7.18
Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med (2003) 6.73
Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol (2004) 5.80
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol (1996) 5.38
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature (1992) 5.04
Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med (2002) 4.67
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med (2000) 4.50
Self-tolerance of natural killer cells. Nat Rev Immunol (2006) 3.75
Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol (2004) 3.41
Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med (2002) 3.35
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A (1998) 3.35
NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med (1994) 2.59
Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med (1998) 2.57
Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science (1992) 2.57
CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat Immunol (2002) 2.40
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol (2006) 2.38
Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med (1997) 2.17
Missing self recognition and self tolerance of natural killer (NK) cells. Semin Immunol (2006) 1.80
T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J Immunol (1999) 1.72
Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J Immunol (2003) 1.72
Regulatory T cells and autoimmune disease. Immunol Rev (2005) 1.51
Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat Med (2000) 1.51
Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 1.28
T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter. J Immunol (1992) 1.24
Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med (2000) 1.23
A low polymorphic mouse H-2 class I gene from the Tla complex is expressed in a broad variety of cell types. J Exp Med (1987) 1.21
The immunoregulatory effects of Qa-1. Immunol Rev (2006) 1.21
Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol (1998) 1.20
Structural and functional characteristics of the class IB molecule, Qa-1. Immunol Rev (1995) 1.12
IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood (2005) 1.12
Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. J Hepatol (2005) 1.11
Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses. J Immunol (1998) 1.05
The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Eur J Immunol (2004) 1.00
Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin. Immunity (2002) 1.00
Elimination in vivo of developing T cells by natural killer cells. J Exp Med (2003) 0.98
Anti-CD3 antibodies: towards clinical antigen-specific immunomodulation. Curr Opin Pharmacol (2004) 0.94
The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells. J Immunol (2006) 0.94
Low doses of interferon alpha result in more effective clinical natural killer cell activation. J Clin Invest (1985) 0.93
Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function. Mult Scler (1995) 0.81
Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease. C R Biol (2006) 0.80
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med (2007) 7.73
Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif. Cell (2008) 4.00
Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol (2006) 3.70
Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature (2010) 3.68
Activity of striatal neurons reflects dynamic encoding and recoding of procedural memories. Nature (2005) 3.63
Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol (2004) 3.41
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest (2003) 3.40
Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity (2004) 3.09
Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol (2005) 3.05
Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A (2010) 2.88
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm (2010) 2.79
The organizing principle in the formation of the T cell receptor-CD3 complex. Cell (2002) 2.74
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med (2007) 2.64
Dynamic analysis of learning in behavioral experiments. J Neurosci (2004) 2.58
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A (2004) 2.50
Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2004) 2.34
Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity (2008) 2.25
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. J Transl Med (2013) 2.04
Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation. Heart Rhythm (2011) 2.01
The structure of the zetazeta transmembrane dimer reveals features essential for its assembly with the T cell receptor. Cell (2006) 1.95
Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8. Heart Rhythm (2011) 1.87
Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J Immunol (2002) 1.85
T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc Natl Acad Sci U S A (2005) 1.83
The assembly of diverse immune receptors is focused on a polar membrane-embedded interaction site. PLoS Biol (2006) 1.83
Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol (2002) 1.80
Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc Natl Acad Sci U S A (2008) 1.77
Detection of autoreactive myelin proteolipid protein 139-151-specific T cells by using MHC II (IAs) tetramers. J Immunol (2003) 1.71
Signaling by the kinase MINK is essential in the negative selection of autoreactive thymocytes. Nat Immunol (2004) 1.65
Haemodynamics-driven developmental pruning of brain vasculature in zebrafish. PLoS Biol (2012) 1.65
The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol (2005) 1.64
Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay. Circulation (2011) 1.60
Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J Clin Invest (2007) 1.58
Common themes in the assembly and architecture of activating immune receptors. Nat Rev Immunol (2007) 1.54
The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. Proc Natl Acad Sci U S A (2005) 1.54
Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol Cell Biol (2008) 1.52
Regulatory T cells and autoimmune disease. Immunol Rev (2005) 1.51
Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity (2012) 1.50
Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol (2009) 1.50
Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant. Heart Rhythm (2012) 1.46
The structural basis for intramembrane assembly of an activating immunoreceptor complex. Nat Immunol (2010) 1.44
Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol (2005) 1.43
Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc Natl Acad Sci U S A (2008) 1.43
CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc Natl Acad Sci U S A (2011) 1.41
Qa-1 restriction of CD8+ suppressor T cells. J Clin Invest (2004) 1.41
Absence of the CD44 gene prevents sarcoma metastasis. Cancer Res (2002) 1.40
Self-reactive human CD4 T cell clones form unusual immunological synapses. J Exp Med (2012) 1.38
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol (2010) 1.38
Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). Eur Heart J (2011) 1.37
Identification of dendritic antigen-presenting cells in the zebrafish. Proc Natl Acad Sci U S A (2010) 1.37
Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors. Immunity (2005) 1.36
A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC. J Exp Med (2011) 1.34
T-bet plays a key role in NK-mediated control of melanoma metastatic disease. J Immunol (2008) 1.32
Molecular mechanisms for the assembly of the T cell receptor-CD3 complex. Mol Immunol (2004) 1.30
Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression. Proc Natl Acad Sci U S A (2008) 1.30
Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J Immunol (2005) 1.28
Stoichiometry of the T-cell receptor-CD3 complex and key intermediates assembled in the endoplasmic reticulum. EMBO J (2004) 1.28
Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm (2008) 1.27
Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc Natl Acad Sci U S A (2011) 1.26
The involvement of sortase A in high virulence of STSS-causing Streptococcus suis serotype 2. Arch Microbiol (2008) 1.23
Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr). PLoS One (2012) 1.23
Ex vivo analysis of thymic CD4 T cells in nonobese diabetic mice with tetramers generated from I-A(g7)/class II-associated invariant chain peptide precursors. J Immunol (2003) 1.22
The immunoregulatory effects of Qa-1. Immunol Rev (2006) 1.21
Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell (2012) 1.21
Reprogramming after chromosome transfer into mouse blastomeres. Curr Biol (2009) 1.20
NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression. FASEB J (2002) 1.20
Stable encoding of task structure coexists with flexible coding of task events in sensorimotor striatum. J Neurophysiol (2009) 1.20
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful. Cancer Immunol Res (2014) 1.17
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. Blood (2009) 1.16
Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol (2003) 1.16
Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association. J Biol Chem (2007) 1.16
Cutting edge: engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia. J Immunol (2008) 1.15
Structural factors contributing to DM susceptibility of MHC class II/peptide complexes. J Immunol (2002) 1.14
TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest (2011) 1.13
Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins. RNA (2012) 1.13
Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. J Clin Invest (2010) 1.13
MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLoS One (2011) 1.12
Generation and regulation of CD8(+) regulatory T cells. Cell Mol Immunol (2008) 1.11
Small molecules that enhance the catalytic efficiency of HLA-DM. J Immunol (2006) 1.10
Structural basis for oligosaccharide recognition of misfolded glycoproteins by OS-9 in ER-associated degradation. Mol Cell (2010) 1.10
Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2. Proc Natl Acad Sci U S A (2010) 1.09
An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma. Expert Rev Vaccines (2013) 1.08
Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J Immunol (2005) 1.08
Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J Clin Invest (2004) 1.08
Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: I. Experimental analysis of the use-dependent block. Am J Physiol Heart Circ Physiol (2011) 1.08
Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome. Circulation (2006) 1.08
Reconstruction of the corneal epithelium with induced marrow mesenchymal stem cells in rats. Mol Vis (2010) 1.07
Suppression of autoimmune diabetes by soluble galectin-1. J Immunol (2009) 1.06
Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells. Semin Immunol (2011) 1.05
A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8. J Immunol (2004) 1.05
Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals. J Clin Invest (2014) 1.04
Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection. J Virol (2008) 1.03